Skip to main content
Erschienen in: Calcified Tissue International 4/2013

01.10.2013 | Original Research

Bone Collagen: New Clues to Its Mineralization Mechanism from Recessive Osteogenesis Imperfecta

verfasst von: David R. Eyre, Mary Ann Weis

Erschienen in: Calcified Tissue International | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Until 2006 the only mutations known to cause osteogenesis imperfecta (OI) were in the two genes coding for type I collagen chains. These dominant mutations affecting the expression or primary sequence of collagen α1(I) and α2(I) chains account for over 90 % of OI cases. Since then a growing list of mutant genes causing the 5–10 % of recessive cases has rapidly emerged. They include CRTAP, LEPRE1, and PPIB, which encode three proteins forming the prolyl 3-hydroxylase complex; PLOD2 and FKBP10, which encode, respectively, lysyl hydroxylase 2 and a foldase required for its activity in forming mature cross-links in bone collagen; SERPINH1, which encodes the collagen chaperone HSP47; SERPINF1, which encodes pigment epithelium-derived factor required for osteoid mineralization; and BMP1, which encodes the type I procollagen C-propeptidase. All cause fragile bone in infancy, which can include overmineralization or undermineralization defects as well as abnormal collagen posttranslational modifications. Consistently both dominant and recessive variants lead to abnormal cross-linking chemistry in bone collagen. These recent discoveries strengthen the potential for a common pathogenic mechanism of misassembled collagen fibrils. Of the new genes identified, eight encode proteins required for collagen posttranslational modification, chaperoning of newly synthesized collagen chains into native molecules, or transport through the endoplasmic reticulum and Golgi for polymerization, cross-linking, and mineralization. In reviewing these findings, we conclude that a common theme is emerging in the pathogenesis of brittle bone disease of mishandled collagen assembly with important insights on posttranslational features of bone collagen that have evolved to optimize it as a biomineral template.
Literatur
1.
Zurück zum Zitat Glimcher MJ (1960) Specificity of the molecular structure of organic matrices in mineralization. In: Sogannes RF (ed) Calcification in biological systems. American Association for the Advancement of Science, Washington, DC Glimcher MJ (1960) Specificity of the molecular structure of organic matrices in mineralization. In: Sogannes RF (ed) Calcification in biological systems. American Association for the Advancement of Science, Washington, DC
2.
Zurück zum Zitat Glimcher MJ (2006) Bone: nature of the calcium phosphate crystals and cellular, structural, and physical chemical mechanisms in their formation. Rev Mineral Geochem 64:223–282CrossRef Glimcher MJ (2006) Bone: nature of the calcium phosphate crystals and cellular, structural, and physical chemical mechanisms in their formation. Rev Mineral Geochem 64:223–282CrossRef
3.
Zurück zum Zitat Morello R, Bertin TK, Chen Y, Hicks J, Tonachini L, Monticone M, Castagnola P, Rauch F, Glorieux FH, Vranka J, Bächinger HP, Pace JM, Schwarze U, Byers PH, Weis MA, Fernandes RJ, Eyre DR, Yao Z, Boyce BF, Lee B (2006) CRTAP is required for prolyl 3-hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell 127(2):291–304PubMedCrossRef Morello R, Bertin TK, Chen Y, Hicks J, Tonachini L, Monticone M, Castagnola P, Rauch F, Glorieux FH, Vranka J, Bächinger HP, Pace JM, Schwarze U, Byers PH, Weis MA, Fernandes RJ, Eyre DR, Yao Z, Boyce BF, Lee B (2006) CRTAP is required for prolyl 3-hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell 127(2):291–304PubMedCrossRef
4.
Zurück zum Zitat Barnes AM, Chang W, Morello R, Cabral WA, Weis MA, Eyre DR, Leikin S, Makareeva E, Kuznetsova N, Uveges TE, Ashok A, Flor AW, Mulvihill JJ, Wilson PL, Sundaram UT, Lee B, Marini JC (2006) Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta. N Engl J Med 355:2757–2764PubMedCrossRef Barnes AM, Chang W, Morello R, Cabral WA, Weis MA, Eyre DR, Leikin S, Makareeva E, Kuznetsova N, Uveges TE, Ashok A, Flor AW, Mulvihill JJ, Wilson PL, Sundaram UT, Lee B, Marini JC (2006) Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta. N Engl J Med 355:2757–2764PubMedCrossRef
5.
Zurück zum Zitat Cabral WA, Chang W, Barnes AM, Weis MA, Scott MA, Leikin S, Makareeva E, Kuznetsova NV, Rosenbaum KN, Tifft CJ, Bulas DI, Kozma C, Smith PA, Eyre DR, Marini JC (2007) Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta. Nat Genet 39(3):359–365PubMedCrossRef Cabral WA, Chang W, Barnes AM, Weis MA, Scott MA, Leikin S, Makareeva E, Kuznetsova NV, Rosenbaum KN, Tifft CJ, Bulas DI, Kozma C, Smith PA, Eyre DR, Marini JC (2007) Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta. Nat Genet 39(3):359–365PubMedCrossRef
6.
Zurück zum Zitat Baldridge D, Schwarze U, Morello R, Lennington J, Bertin TK, Pace JM, Pepin MG, Weis M, Eyre DR, Walsh J, Lambert D, Green A, Robinson H, Michelson M, Houge G, Lindman C, Martin J, Ward J, Lemyre E, Mitchell JJ, Krakow D, Rimoin DL, Cohn DH, Byers PH, Lee B (2008) CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta. Hum Mutat 29(12):1435–1442PubMedCrossRef Baldridge D, Schwarze U, Morello R, Lennington J, Bertin TK, Pace JM, Pepin MG, Weis M, Eyre DR, Walsh J, Lambert D, Green A, Robinson H, Michelson M, Houge G, Lindman C, Martin J, Ward J, Lemyre E, Mitchell JJ, Krakow D, Rimoin DL, Cohn DH, Byers PH, Lee B (2008) CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta. Hum Mutat 29(12):1435–1442PubMedCrossRef
7.
Zurück zum Zitat vanDijk FS, Nesbitt IM, Zwikstra EH, Nikkels PGJ, Piersma SR, Fratantoni SA, Jimenez CR, Huizer M, Morsman AC, Cobben JM, van Roij MHH, Elting MW, Verbeke MIJL, Wijnaendts LCD, Shaw NJ, Högler W, McKeown C, Sistermans EA, Dalton A, Meijers-Jeijboer H, Pals G (2009) PPIB mutations cause severe osteogenesis imperfecta. Am J Hum Genet 85:521–527CrossRef vanDijk FS, Nesbitt IM, Zwikstra EH, Nikkels PGJ, Piersma SR, Fratantoni SA, Jimenez CR, Huizer M, Morsman AC, Cobben JM, van Roij MHH, Elting MW, Verbeke MIJL, Wijnaendts LCD, Shaw NJ, Högler W, McKeown C, Sistermans EA, Dalton A, Meijers-Jeijboer H, Pals G (2009) PPIB mutations cause severe osteogenesis imperfecta. Am J Hum Genet 85:521–527CrossRef
8.
Zurück zum Zitat Barnes AM, Carter EM, Cabral WA, Weis MA, Chang W, Makareeva E, Leikin S, Rotimi CN, Eyre DR, Raggio CL, Marini JC (2010) Lack of cyclophilin B in osteogenesis imperfecta with normal collagen folding. N Engl J Med 362:521–528PubMedCrossRef Barnes AM, Carter EM, Cabral WA, Weis MA, Chang W, Makareeva E, Leikin S, Rotimi CN, Eyre DR, Raggio CL, Marini JC (2010) Lack of cyclophilin B in osteogenesis imperfecta with normal collagen folding. N Engl J Med 362:521–528PubMedCrossRef
9.
Zurück zum Zitat Drögemüller C, Becker D, Brunner A, Haase B, Kircher P, Seeliger F, Fehr M, Baumann U, Lindblad-Toh K, Leeb T (2009) A missense mutation in the SERPINH1 gene in dachshunds with osteogenesis imperfecta. PLoS Genet 5(7):e1000579PubMedCrossRef Drögemüller C, Becker D, Brunner A, Haase B, Kircher P, Seeliger F, Fehr M, Baumann U, Lindblad-Toh K, Leeb T (2009) A missense mutation in the SERPINH1 gene in dachshunds with osteogenesis imperfecta. PLoS Genet 5(7):e1000579PubMedCrossRef
10.
Zurück zum Zitat Christiansen HE, Schwarze U, Pyott SM, AlSwaid A, Al Balwi M, Alrasheed S, Pepin MG, Weis MA, Eyre DR, Byers PH (2010) Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta. Am J Hum Genet 86:389–398PubMedCrossRef Christiansen HE, Schwarze U, Pyott SM, AlSwaid A, Al Balwi M, Alrasheed S, Pepin MG, Weis MA, Eyre DR, Byers PH (2010) Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta. Am J Hum Genet 86:389–398PubMedCrossRef
11.
Zurück zum Zitat Alanay Y, Avaygan H, Camacho N, Utine GE, Boduroglu K, Aktas D, Alikasifoglu M, Tuncbilek E, Orhan D, Bakar FT, Zabel B, Superti-Furga A, Bruckner-Tuderman L, Curry CJ, Pyott S, Byers PH, Eyre DR, Baldridge D, Lee B, Merrill AE, Davis EC, Cohn DH, Akarsu N, Krakow D (2010) Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta. Am J Hum Genet 86:551–559PubMedCrossRef Alanay Y, Avaygan H, Camacho N, Utine GE, Boduroglu K, Aktas D, Alikasifoglu M, Tuncbilek E, Orhan D, Bakar FT, Zabel B, Superti-Furga A, Bruckner-Tuderman L, Curry CJ, Pyott S, Byers PH, Eyre DR, Baldridge D, Lee B, Merrill AE, Davis EC, Cohn DH, Akarsu N, Krakow D (2010) Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta. Am J Hum Genet 86:551–559PubMedCrossRef
12.
Zurück zum Zitat Kelley BP, Malfait F, Bonafe L, Baldridge D, Homan E, Symoens S, Willaert A, Elcioglu N, Van Maldergem L, Verellen-Dumoulin C, Gillerot Y, Napierala D, Krakow D, Beighton P, Supert-Furga A, De Paepe A, Lee B (2011) Mutations in FKBP10 cause recessive osteogenesis imperfecta and Bruck syndrome. J Bone Miner Res 26(3):666–672PubMedCrossRef Kelley BP, Malfait F, Bonafe L, Baldridge D, Homan E, Symoens S, Willaert A, Elcioglu N, Van Maldergem L, Verellen-Dumoulin C, Gillerot Y, Napierala D, Krakow D, Beighton P, Supert-Furga A, De Paepe A, Lee B (2011) Mutations in FKBP10 cause recessive osteogenesis imperfecta and Bruck syndrome. J Bone Miner Res 26(3):666–672PubMedCrossRef
13.
Zurück zum Zitat Barnes AM, Cabral WA, Weis M, Makareeva E, Merta EL, Leikin S, Eyre D, Trujillo C, Marini JC (2012) Absence of FKBP10 in recessive type XI OI leads to diminished collagen cross-linking and reduced collagen deposition in extracellular matrix. Hum Mutat 33:1589–1598PubMedCrossRef Barnes AM, Cabral WA, Weis M, Makareeva E, Merta EL, Leikin S, Eyre D, Trujillo C, Marini JC (2012) Absence of FKBP10 in recessive type XI OI leads to diminished collagen cross-linking and reduced collagen deposition in extracellular matrix. Hum Mutat 33:1589–1598PubMedCrossRef
14.
Zurück zum Zitat Schwarze U, Cundy T, Pyott SM, Christiansen HE, Hegde MR, Bank RA, Pals G, Ankala A, Conneely K, Seaver L, Yandow SM, Raney E, Babovic-Vuksanovic D, Stoler J, Ben-Neriah Z, Segel R, Lieberman S, Siderius L, Al-Aqeel A, Hannibal M, Hudgins L, McPherson E, Clemens M, Sussman MD, Steiner RD, Mahan J, Smith R, Anyane-Yeboa K, Wynn J, Chong K, Uster T, Aftimos S, Sutton VR, Davis EC, Kim LS, Weis MA, Eyre D, Byers PH (2013) Mutations in FKBP10, which result in Bruck syndrome and recessive forms of osteogenesis imperfecta, inhibit the hydroxylation of telopeptide lysines on bone collagen. Hum Mol Genet 22:1–17PubMedCrossRef Schwarze U, Cundy T, Pyott SM, Christiansen HE, Hegde MR, Bank RA, Pals G, Ankala A, Conneely K, Seaver L, Yandow SM, Raney E, Babovic-Vuksanovic D, Stoler J, Ben-Neriah Z, Segel R, Lieberman S, Siderius L, Al-Aqeel A, Hannibal M, Hudgins L, McPherson E, Clemens M, Sussman MD, Steiner RD, Mahan J, Smith R, Anyane-Yeboa K, Wynn J, Chong K, Uster T, Aftimos S, Sutton VR, Davis EC, Kim LS, Weis MA, Eyre D, Byers PH (2013) Mutations in FKBP10, which result in Bruck syndrome and recessive forms of osteogenesis imperfecta, inhibit the hydroxylation of telopeptide lysines on bone collagen. Hum Mol Genet 22:1–17PubMedCrossRef
15.
Zurück zum Zitat Martinez-Glez V, Valencia M, Caparrós-Martin JA, Aglan M, Temtamy S, Tenorio J, Pulido V, Lindert U, Rohrbach M, Eyre D, Giunta C, Lapunzina P, Ruiz-Perez VL (2012) Identification of a mutation causing deficient BMP1m/mTLD proteolytic activity in autosomal recessive osteogenesis imperfecta. Hum Mutat 33:343–350PubMedCrossRef Martinez-Glez V, Valencia M, Caparrós-Martin JA, Aglan M, Temtamy S, Tenorio J, Pulido V, Lindert U, Rohrbach M, Eyre D, Giunta C, Lapunzina P, Ruiz-Perez VL (2012) Identification of a mutation causing deficient BMP1m/mTLD proteolytic activity in autosomal recessive osteogenesis imperfecta. Hum Mutat 33:343–350PubMedCrossRef
16.
Zurück zum Zitat Asharani PV, Keupp K, Semler O, Wang W, Li Y, Thiele H, Yigi G, Pohl E, Becker J, Frommolt P, Sonntag C, Altmüller J, Zimmermann K, Greenspan DS, Akarsu NA, Netzer C, Schönau E, Wirth R, Hammerschmidt M, Nürnberg P, Sollnik B, Carney TJ (2012) Attenuated BMP1 function compromises osteogenesis, leading to bone fragility in humans and zebrafish. Am J Hum Genet 90:661–674PubMedCrossRef Asharani PV, Keupp K, Semler O, Wang W, Li Y, Thiele H, Yigi G, Pohl E, Becker J, Frommolt P, Sonntag C, Altmüller J, Zimmermann K, Greenspan DS, Akarsu NA, Netzer C, Schönau E, Wirth R, Hammerschmidt M, Nürnberg P, Sollnik B, Carney TJ (2012) Attenuated BMP1 function compromises osteogenesis, leading to bone fragility in humans and zebrafish. Am J Hum Genet 90:661–674PubMedCrossRef
17.
18.
Zurück zum Zitat Vranka JA, Sakai LY, Bächinger HP (2004) Prolyl 3-hydroxylase 1, enzyme characterization and identification of a novel family of enzymes. J Biol Chem 279:23615–23621PubMedCrossRef Vranka JA, Sakai LY, Bächinger HP (2004) Prolyl 3-hydroxylase 1, enzyme characterization and identification of a novel family of enzymes. J Biol Chem 279:23615–23621PubMedCrossRef
19.
Zurück zum Zitat Weis MA, Hudson DM, Kim L, Scott M, Wu JJ, Eyre DR (2010) Location of 3-hydroxyproline residues in collagen types I, II, III, and V/XI implies a role in fibril supramolecular assembly. J Biol Chem 285(4):2580–2590PubMedCrossRef Weis MA, Hudson DM, Kim L, Scott M, Wu JJ, Eyre DR (2010) Location of 3-hydroxyproline residues in collagen types I, II, III, and V/XI implies a role in fibril supramolecular assembly. J Biol Chem 285(4):2580–2590PubMedCrossRef
20.
Zurück zum Zitat Becker J, Semler O, Gilissen C, Li Y, Bolz HJ, Giunta C, Bergmann C, Rohrbach M, Koerber F, Zimmermann K (2011) Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta. Am J Hum Genet 88:362–371PubMedCrossRef Becker J, Semler O, Gilissen C, Li Y, Bolz HJ, Giunta C, Bergmann C, Rohrbach M, Koerber F, Zimmermann K (2011) Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta. Am J Hum Genet 88:362–371PubMedCrossRef
21.
Zurück zum Zitat Homan EP, Rauch F, Grafe I, Lietman C, Doll JA, Dawson B, Bertin T, Napierala D, Morello R, Gibbs R, White L, Miki R, Cohn DH, Crawford S, Travers R, Glorieux FH, Lee B (2011) Mutations in SERPINF1 cause osteogenesis imperfecta type VI. J Bone Miner Res 26:2798–2803PubMedCrossRef Homan EP, Rauch F, Grafe I, Lietman C, Doll JA, Dawson B, Bertin T, Napierala D, Morello R, Gibbs R, White L, Miki R, Cohn DH, Crawford S, Travers R, Glorieux FH, Lee B (2011) Mutations in SERPINF1 cause osteogenesis imperfecta type VI. J Bone Miner Res 26:2798–2803PubMedCrossRef
22.
Zurück zum Zitat Cho TJ, Lee KE, Lee SK, Song S, Kim K, Jeon D, Lee G, Kim HN, Lee H, Eom HH, Lee Z, Kim O-H, Park WY, Park S, Ikegawa S, Yoo W, Choi I, Kim JW (2012) A single recurrent mutation in the 5′-UTR of IFITM5 causes osteogenesis imperfecta type V. Am J Hum Genet 91:343–348PubMedCrossRef Cho TJ, Lee KE, Lee SK, Song S, Kim K, Jeon D, Lee G, Kim HN, Lee H, Eom HH, Lee Z, Kim O-H, Park WY, Park S, Ikegawa S, Yoo W, Choi I, Kim JW (2012) A single recurrent mutation in the 5′-UTR of IFITM5 causes osteogenesis imperfecta type V. Am J Hum Genet 91:343–348PubMedCrossRef
23.
Zurück zum Zitat Semler O, Garbes L, Keupp K, Swan D, Zimmermann K, Becker J, Iden S, Wirth B, Eyse P, Koerber F, Schoenau E, Bohlander SK, Wollnik B, Netzer C (2012) A mutation in the 5′-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus. Am J Hum Genet 91:349–357PubMedCrossRef Semler O, Garbes L, Keupp K, Swan D, Zimmermann K, Becker J, Iden S, Wirth B, Eyse P, Koerber F, Schoenau E, Bohlander SK, Wollnik B, Netzer C (2012) A mutation in the 5′-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus. Am J Hum Genet 91:349–357PubMedCrossRef
24.
Zurück zum Zitat Ha-Vinh R, Alanay Y, Bank RA, Campos-Xavier AB, Zankl A, Superti-Furga A, Bonafé L (2004) Phenotypic and molecular characterization of Bruck syndrome (osteogenesis imperfecta with contractures of the large joints) caused by a recessive mutation in PLOD2. Am J Med Genet A 131:115–120PubMedCrossRef Ha-Vinh R, Alanay Y, Bank RA, Campos-Xavier AB, Zankl A, Superti-Furga A, Bonafé L (2004) Phenotypic and molecular characterization of Bruck syndrome (osteogenesis imperfecta with contractures of the large joints) caused by a recessive mutation in PLOD2. Am J Med Genet A 131:115–120PubMedCrossRef
25.
Zurück zum Zitat Bank RA, Robins SP, Wijmenga C, Breslau-Siderius LJ, Bardoel AF, van der Sluijs HA, Pruijs HE, TeKoppele JM (1999) Defective collagen crosslinking in bone, but not in ligament or cartilage, in Bruck syndrome: indications for a bone-specific telopeptide lysyl hydroxylase on chromosome 17. Proc Natl Acad Sci USA 96:1054–1058PubMedCrossRef Bank RA, Robins SP, Wijmenga C, Breslau-Siderius LJ, Bardoel AF, van der Sluijs HA, Pruijs HE, TeKoppele JM (1999) Defective collagen crosslinking in bone, but not in ligament or cartilage, in Bruck syndrome: indications for a bone-specific telopeptide lysyl hydroxylase on chromosome 17. Proc Natl Acad Sci USA 96:1054–1058PubMedCrossRef
26.
Zurück zum Zitat Lapunzina P, Aglan M, Temtamy S, Caparrós-Martin JA, Valencia M, Letón R, Martinez-Glez V, Elhossini R, Arm K, Vilaboa N, Ruiz-Perez VL (2010) Identification of a frameshift mutation in Osterix in a patient with recessive osteogenesis imperfecta. Am J Hum Genet 87:110–114PubMedCrossRef Lapunzina P, Aglan M, Temtamy S, Caparrós-Martin JA, Valencia M, Letón R, Martinez-Glez V, Elhossini R, Arm K, Vilaboa N, Ruiz-Perez VL (2010) Identification of a frameshift mutation in Osterix in a patient with recessive osteogenesis imperfecta. Am J Hum Genet 87:110–114PubMedCrossRef
27.
Zurück zum Zitat Korvala J, Jüppner H, Mäkitie O, Sochett E, Schnabel D, Mora S, Bartels CF, Warman ML, Deraska D, Cole WG, Hartikka H, Ala-Kokko L, Männikö M (2012) Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity. BMC Med Genet 13:26PubMedCrossRef Korvala J, Jüppner H, Mäkitie O, Sochett E, Schnabel D, Mora S, Bartels CF, Warman ML, Deraska D, Cole WG, Hartikka H, Ala-Kokko L, Männikö M (2012) Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity. BMC Med Genet 13:26PubMedCrossRef
28.
Zurück zum Zitat Cui Y, Niziolek PJ, MacDonald BT, Zylstra CR, Alenina N, Robinson DR, Zhong Z, Matthes S, Jacobsen CM, Conlon RA, Brommage R, Liu Q, Mseeh F, Powell DR, Yang QM, Zambrowicz B, Gerrits H, Gossen JA, He X, Bader M, Williams BO, Warman ML, Robling AG (2011) Lrp5 functions in bone to regulate bone mass. Nat Med 17(6):684–691PubMedCrossRef Cui Y, Niziolek PJ, MacDonald BT, Zylstra CR, Alenina N, Robinson DR, Zhong Z, Matthes S, Jacobsen CM, Conlon RA, Brommage R, Liu Q, Mseeh F, Powell DR, Yang QM, Zambrowicz B, Gerrits H, Gossen JA, He X, Bader M, Williams BO, Warman ML, Robling AG (2011) Lrp5 functions in bone to regulate bone mass. Nat Med 17(6):684–691PubMedCrossRef
29.
Zurück zum Zitat Niyibizi C, Eyre DR (1989) Identification of the cartilage alpha 1(XI) chain in type v collagen from bovine bone. FEBS Lett 242:218–314CrossRef Niyibizi C, Eyre DR (1989) Identification of the cartilage alpha 1(XI) chain in type v collagen from bovine bone. FEBS Lett 242:218–314CrossRef
30.
Zurück zum Zitat Wu JJ, Weis MA, Kim LS, Carter BG, Eyre DR (2009) Differences in chain usage and cross-linking specificities of cartilage type V/XI collagen isoforms with age and tissue. J Biol Chem 284:5539–5545PubMedCrossRef Wu JJ, Weis MA, Kim LS, Carter BG, Eyre DR (2009) Differences in chain usage and cross-linking specificities of cartilage type V/XI collagen isoforms with age and tissue. J Biol Chem 284:5539–5545PubMedCrossRef
31.
32.
Zurück zum Zitat Hanson DA, Eyre DR (1996) Molecular site specificity of pyridinoline and pyrrole cross-links in type I collagen of human bone. J Biol Chem 271(43):26508–26516PubMedCrossRef Hanson DA, Eyre DR (1996) Molecular site specificity of pyridinoline and pyrrole cross-links in type I collagen of human bone. J Biol Chem 271(43):26508–26516PubMedCrossRef
33.
Zurück zum Zitat Kuypers R, Tyler M, Kurth LB, Jenkins ID, Horgan DJ (1992) Identification of the loci of the collagen-associated Ehrlich chromogen in type I collagen confirms its role as a trivalent cross-link. Biochem J 283:129–136PubMed Kuypers R, Tyler M, Kurth LB, Jenkins ID, Horgan DJ (1992) Identification of the loci of the collagen-associated Ehrlich chromogen in type I collagen confirms its role as a trivalent cross-link. Biochem J 283:129–136PubMed
34.
Zurück zum Zitat Banse X, Devogelaer JP, Lafosse A, Sims TJ, Grynpas M, Bailey AJ (2002) Cross-link profile of bone collagen correlates with structural organization of trabeculae. Bone 31:70–76PubMedCrossRef Banse X, Devogelaer JP, Lafosse A, Sims TJ, Grynpas M, Bailey AJ (2002) Cross-link profile of bone collagen correlates with structural organization of trabeculae. Bone 31:70–76PubMedCrossRef
35.
Zurück zum Zitat McNab H, Monahan LC (2008) 3-Hydroxypyrroles. In: Jones RA (ed) Chemistry of heterocyclic compounds: pyrroles. Part 2: the synthesis, reactivity, and physical properties of substituted pyrroles, vol 48. Wiley, Hoboken McNab H, Monahan LC (2008) 3-Hydroxypyrroles. In: Jones RA (ed) Chemistry of heterocyclic compounds: pyrroles. Part 2: the synthesis, reactivity, and physical properties of substituted pyrroles, vol 48. Wiley, Hoboken
36.
Zurück zum Zitat Kemp PD, Scott JE (1986) Ehrlich chromogens, probable cross-links in elastin and collagen. Biochem J 252:387–393 Kemp PD, Scott JE (1986) Ehrlich chromogens, probable cross-links in elastin and collagen. Biochem J 252:387–393
37.
Zurück zum Zitat Bank RA, TeKoppele JM, Janus GJ, Wassen MH, Pruijs HE, Van der Sluijs HA, Sakkers RJ (2000) Pyridinium cross-links in bone of patients with osteogenesis imperfecta: evidence of a normal intrafibrillar collagen packing. J Bone Miner Res 15:1330–1336PubMedCrossRef Bank RA, TeKoppele JM, Janus GJ, Wassen MH, Pruijs HE, Van der Sluijs HA, Sakkers RJ (2000) Pyridinium cross-links in bone of patients with osteogenesis imperfecta: evidence of a normal intrafibrillar collagen packing. J Bone Miner Res 15:1330–1336PubMedCrossRef
38.
Zurück zum Zitat Eyre D, Shao P, Weis MA, Steinmann B (2002) The kyphoscoliotic type of Ehlers-Danlos syndrome (type VI): differential effects on the hydroxylation of lysine in collagens I and II revealed by analysis of cross-linked telopeptides from urine. Mol Genet Metab 76:211–216PubMedCrossRef Eyre D, Shao P, Weis MA, Steinmann B (2002) The kyphoscoliotic type of Ehlers-Danlos syndrome (type VI): differential effects on the hydroxylation of lysine in collagens I and II revealed by analysis of cross-linked telopeptides from urine. Mol Genet Metab 76:211–216PubMedCrossRef
39.
Zurück zum Zitat Rohrbach M, Giunta C (2012) Recessive osteogenesis imperfecta: clinical, radiological and molecular findings. Am J Med Genet 160C:175–189PubMedCrossRef Rohrbach M, Giunta C (2012) Recessive osteogenesis imperfecta: clinical, radiological and molecular findings. Am J Med Genet 160C:175–189PubMedCrossRef
40.
Zurück zum Zitat Berg RA, Prockop DJ (1973) The thermal transition of a non-hydroxylated form of collagen. Evidence for a role for hydroxyproline in stabilizing the triple-helix of collagen. Biochem Biophys Res Commun 52:115–120PubMedCrossRef Berg RA, Prockop DJ (1973) The thermal transition of a non-hydroxylated form of collagen. Evidence for a role for hydroxyproline in stabilizing the triple-helix of collagen. Biochem Biophys Res Commun 52:115–120PubMedCrossRef
41.
Zurück zum Zitat Hudson DM, Kim LS, Weis M, Cohn DH, Eyre DR (2012) Peptidyl 3-hydroxyproline binding properties of type I collagen suggest a function in fibril supramolecular assembly. Biochemistry 51:2417–2424PubMedCrossRef Hudson DM, Kim LS, Weis M, Cohn DH, Eyre DR (2012) Peptidyl 3-hydroxyproline binding properties of type I collagen suggest a function in fibril supramolecular assembly. Biochemistry 51:2417–2424PubMedCrossRef
42.
Zurück zum Zitat Schumacher MA, Mizuno K, Bächinger HP (2006) The crystal structure of a collagen-like polypeptide with 3(S)-hydroxyproline residues in the Xaa position forms a standard 7/2 collagen triple helix. J Biol Chem 281:27566–27574PubMedCrossRef Schumacher MA, Mizuno K, Bächinger HP (2006) The crystal structure of a collagen-like polypeptide with 3(S)-hydroxyproline residues in the Xaa position forms a standard 7/2 collagen triple helix. J Biol Chem 281:27566–27574PubMedCrossRef
43.
Zurück zum Zitat Yang C, Park AC, Davis NA, Russell JD, Kim B, Brand DD, Lawrence MJ, Ge Y, Westphall MS, Coon JJ, Greenspan DS (2012) Comprehensive mass spectrometric mapping of the hydroxylated amino acid residues of the α1(V) collagen chain. J Biol Chem 287:40598–40610PubMedCrossRef Yang C, Park AC, Davis NA, Russell JD, Kim B, Brand DD, Lawrence MJ, Ge Y, Westphall MS, Coon JJ, Greenspan DS (2012) Comprehensive mass spectrometric mapping of the hydroxylated amino acid residues of the α1(V) collagen chain. J Biol Chem 287:40598–40610PubMedCrossRef
44.
Zurück zum Zitat Sweeney SM, Orgel JP, Fertala A, McAuliffe JD, Turner KR, Di Lullo GA, Chen S, Antipova O, Perumal S, Ala-Kokko L, Forlino A, Cabral WA, Barnes AM, Marini JC, San Antonio JD (2008) Candidate cell and matrix interaction domains on the collagen fibril, the predominant protein of vertebrates. J Biol Chem 283:21187–21197PubMedCrossRef Sweeney SM, Orgel JP, Fertala A, McAuliffe JD, Turner KR, Di Lullo GA, Chen S, Antipova O, Perumal S, Ala-Kokko L, Forlino A, Cabral WA, Barnes AM, Marini JC, San Antonio JD (2008) Candidate cell and matrix interaction domains on the collagen fibril, the predominant protein of vertebrates. J Biol Chem 283:21187–21197PubMedCrossRef
45.
Zurück zum Zitat Kalamajski S, Oldberg Å (2010) The role of small leucine-rich proteoglycans in collagen fibrillogenesis. Matrix Biol 29:248–253PubMedCrossRef Kalamajski S, Oldberg Å (2010) The role of small leucine-rich proteoglycans in collagen fibrillogenesis. Matrix Biol 29:248–253PubMedCrossRef
46.
Zurück zum Zitat Ehrlich H, Deutzmann R, Brunner E, Cappellini E, Koon H, Solazzo C, Yang Y, Ashford D, Thomas-Oates J, Lubeck M, Baessmann C, Langrock T, Hoffmann R, Wörheide G, Reitner J, Simon P, Tsurkan M, Ereskovsky AV, Kurek D, Bazhenov VV, Hunoldt S, Mertig M, Vyalikh DV, Molodtsov SL, Kummer K, Worch H, Smetacek V, Collins MJ (2010) Mineralization of the metre-long biosilica structures of glass sponges is template on hydroxylated collagen. Nat Chem 2:1084–1088PubMedCrossRef Ehrlich H, Deutzmann R, Brunner E, Cappellini E, Koon H, Solazzo C, Yang Y, Ashford D, Thomas-Oates J, Lubeck M, Baessmann C, Langrock T, Hoffmann R, Wörheide G, Reitner J, Simon P, Tsurkan M, Ereskovsky AV, Kurek D, Bazhenov VV, Hunoldt S, Mertig M, Vyalikh DV, Molodtsov SL, Kummer K, Worch H, Smetacek V, Collins MJ (2010) Mineralization of the metre-long biosilica structures of glass sponges is template on hydroxylated collagen. Nat Chem 2:1084–1088PubMedCrossRef
47.
Zurück zum Zitat Donoghue PCJ, Sansom IJ, Downs JP (2006) Early evolution of vertebrate skeletal tissues and cellular interactions, and the canalization of skeletal development. J Exp Zool B Mol Dev Evol 306:278–294PubMedCrossRef Donoghue PCJ, Sansom IJ, Downs JP (2006) Early evolution of vertebrate skeletal tissues and cellular interactions, and the canalization of skeletal development. J Exp Zool B Mol Dev Evol 306:278–294PubMedCrossRef
48.
Zurück zum Zitat Widmer C, Gebauer JM, Brunstein E, Rosenbaum S, Zaucke F, Drögemüller C, Leeb T, Baumann U (2012) Molecular basis for the action of the collagen-specific chaperone Hsp47/SERPINH1 and its structure-specific client recognition. Proc Natl Acad Sci USA 109(33):13243–13247PubMedCrossRef Widmer C, Gebauer JM, Brunstein E, Rosenbaum S, Zaucke F, Drögemüller C, Leeb T, Baumann U (2012) Molecular basis for the action of the collagen-specific chaperone Hsp47/SERPINH1 and its structure-specific client recognition. Proc Natl Acad Sci USA 109(33):13243–13247PubMedCrossRef
49.
Zurück zum Zitat Glorieux FH, Ward LM, Rauch F, Lalic L, Roughley PJ, Travers R (2002) Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect. J Bone Miner Res 17:30–38PubMedCrossRef Glorieux FH, Ward LM, Rauch F, Lalic L, Roughley PJ, Travers R (2002) Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect. J Bone Miner Res 17:30–38PubMedCrossRef
50.
Zurück zum Zitat Lindahl K, Barnes AM, Fratzl-Zelman N, Whyte MP, Hefferan TE, Makareeva E, Brusel M, Yaszemski MJ, Rubin C-J, Kindmark A, Roschger P, Klaushofer K, McAlister WH, Mumm S, Leikin S, Kessler E, Boskey AL, Ljunggren O, Marini JC (2011) COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta. Hum Mutat 32:598–609PubMedCrossRef Lindahl K, Barnes AM, Fratzl-Zelman N, Whyte MP, Hefferan TE, Makareeva E, Brusel M, Yaszemski MJ, Rubin C-J, Kindmark A, Roschger P, Klaushofer K, McAlister WH, Mumm S, Leikin S, Kessler E, Boskey AL, Ljunggren O, Marini JC (2011) COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta. Hum Mutat 32:598–609PubMedCrossRef
51.
Zurück zum Zitat Uzel MI, Scott IC, Babakhanlou-Chase H, Palamakumbura AH, Pappano WM, Hong H-H, Greenspan DS, Trackman PC (2001) Multiple bone morphogenetic protein 1-related mammalian metalloproteinases process pro-lysyl oxidase at the correct physiological site and control lysyl oxidase activation in mouse embryo fibroblast cultures. J Biol Chem 276:22537–22543PubMedCrossRef Uzel MI, Scott IC, Babakhanlou-Chase H, Palamakumbura AH, Pappano WM, Hong H-H, Greenspan DS, Trackman PC (2001) Multiple bone morphogenetic protein 1-related mammalian metalloproteinases process pro-lysyl oxidase at the correct physiological site and control lysyl oxidase activation in mouse embryo fibroblast cultures. J Biol Chem 276:22537–22543PubMedCrossRef
52.
Zurück zum Zitat Shapiro JR, Lietman C, Grover M, Lu JT, Nagamani SCS, Dawson BC, Baldridge DM, Bainbridge MN, Cohn DH, Blazo M, Robers TT, Brennen F-S, Wu Y, Gibbs RA, Melvin P, Campeau PM, Lee BH (2013) Phenotypic variability of osteogenesis imperfecta type V caused by an IFITM5 mutation. J Bone Miner Res. doi:10.1002/jbmr.1891 Shapiro JR, Lietman C, Grover M, Lu JT, Nagamani SCS, Dawson BC, Baldridge DM, Bainbridge MN, Cohn DH, Blazo M, Robers TT, Brennen F-S, Wu Y, Gibbs RA, Melvin P, Campeau PM, Lee BH (2013) Phenotypic variability of osteogenesis imperfecta type V caused by an IFITM5 mutation. J Bone Miner Res. doi:10.​1002/​jbmr.​1891
53.
Zurück zum Zitat Moffatt P, Gaumond M-H, Salois P, Sellin K, Bessette M-C, Godin E, Tambasco de Oliveira P, Atkins GJ, Nanci A, Thomas G (2008) Bril: a novel bone-specific modulator of mineralization. J Bone Miner Res 23:1497–1507PubMedCrossRef Moffatt P, Gaumond M-H, Salois P, Sellin K, Bessette M-C, Godin E, Tambasco de Oliveira P, Atkins GJ, Nanci A, Thomas G (2008) Bril: a novel bone-specific modulator of mineralization. J Bone Miner Res 23:1497–1507PubMedCrossRef
54.
Zurück zum Zitat Hanagata N, Li X, Morita H, Takemura T, Li J, Minowa T (2011) Characterization of the osteoblast-specific transmembrane protein IFITM5 and analysis of IFITM5-deficient mice. J Bone Miner Metab 29:279–290PubMedCrossRef Hanagata N, Li X, Morita H, Takemura T, Li J, Minowa T (2011) Characterization of the osteoblast-specific transmembrane protein IFITM5 and analysis of IFITM5-deficient mice. J Bone Miner Metab 29:279–290PubMedCrossRef
55.
Zurück zum Zitat Nikitovic D, Aggelidakis J, Young MF, Iozzo RV, Karamanos NK, Tzanakakis GN (2012) The biology of small leucine-rich proteoglycans in bone pathophysiology. J Biol Chem 287:33926–33933PubMedCrossRef Nikitovic D, Aggelidakis J, Young MF, Iozzo RV, Karamanos NK, Tzanakakis GN (2012) The biology of small leucine-rich proteoglycans in bone pathophysiology. J Biol Chem 287:33926–33933PubMedCrossRef
56.
Zurück zum Zitat Nikdin H, Olsson M-L, Hultenby K, Sugars RV (2012) Osteoadherin accumulates in the predentin towards the mineralization front in the developing tooth. PLoS One 7:1–12CrossRef Nikdin H, Olsson M-L, Hultenby K, Sugars RV (2012) Osteoadherin accumulates in the predentin towards the mineralization front in the developing tooth. PLoS One 7:1–12CrossRef
57.
Zurück zum Zitat Vanleene M, Porter A, Guillot P-V, Boyde A, Oyen M, Shefelbine S (2012) Ultra-structural defects cause low bone matrix stiffness despite high mineralization in osteogenesis imperfecta mice. Bone 50:1317–1323PubMedCrossRef Vanleene M, Porter A, Guillot P-V, Boyde A, Oyen M, Shefelbine S (2012) Ultra-structural defects cause low bone matrix stiffness despite high mineralization in osteogenesis imperfecta mice. Bone 50:1317–1323PubMedCrossRef
Metadaten
Titel
Bone Collagen: New Clues to Its Mineralization Mechanism from Recessive Osteogenesis Imperfecta
verfasst von
David R. Eyre
Mary Ann Weis
Publikationsdatum
01.10.2013
Verlag
Springer US
Erschienen in
Calcified Tissue International / Ausgabe 4/2013
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-013-9723-9

Weitere Artikel der Ausgabe 4/2013

Calcified Tissue International 4/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.